• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非肝硬化性门静脉纤维化:一种疾病,多种命名?一项对终末期慢性肝病原位肝移植标本进行形态学研究的分析。

Non-cirrhotic portal fibrosis: one disease with many names? An analysis from morphological study of native explant livers with end stage chronic liver disease.

机构信息

Department of Pathology, Sir Ganga Ram Hospital, New Delhi, India.

出版信息

J Clin Pathol. 2011 Jul;64(7):592-8. doi: 10.1136/jcp.2010.087395.

DOI:10.1136/jcp.2010.087395
PMID:21685145
Abstract

BACKGROUND

A group of non-cirrhotic chronic liver diseases, all with sustained portal hypertension and clinically mistaken as cirrhosis, have been described under various names, apparently because of differences in pathological features. The pathogenesis is uncertain and they were believed to have a good prognosis until it was recently shown, from study of explant livers, that they had progressed to end stage disease, needing liver transplantation.

AIMS

To describe detailed morphological features of such end stage non-cirrhotic disease and examine whether the diseases bearing various names are different or represent variable morphological expressions of one entity.

METHODS

Morphological features of 10 native explant livers from patients with pre-transplant diagnosis of end stage cirrhosis but finally categorised as non-cirrhotic portal fibrosis were analysed along with the relevant clinical information.

RESULTS

Besides absence of criteria for cirrhosis, variable grades of obliterative changes in portal vein branches and portal fibrosis were consistently seen in all livers. Fibrous intimal thickening with luminal compromise in some medium and large sized portal veins was randomly distributed but appeared characteristic of this disease, very likely representing organised mural thrombi. Areas of closely placed nodular hyperplastic parenchyma separated by compressed hepatocytes, megasinusoids and peliotic changes were seen only in a proportion of cases.

CONCLUSION

Non-cirrhotic portal fibrosis is a justifiable name for this disease that can progress to end stage liver disease. It represents a single entity that has been considered as different diseases and given various names on the basis of the dominant element in its heterogeneous morphological manifestation.

摘要

背景

一组非肝硬化的慢性肝病,均伴有持续的门静脉高压,并在临床上误诊为肝硬化,它们以不同的名称被描述,显然是由于病理特征的差异。其发病机制尚不清楚,并且由于研究表明它们已经进展为终末期疾病,需要进行肝移植,因此人们认为它们的预后良好。

目的

描述这种终末期非肝硬化疾病的详细形态学特征,并检查具有不同名称的疾病是否不同,或者是否代表同一实体的不同形态学表现。

方法

分析了 10 例来自于终末期肝硬化但最终归类为非肝硬化性门静脉纤维化的患者的移植前肝组织标本的形态学特征,并结合相关的临床资料进行分析。

结果

除了缺乏肝硬化的标准外,所有肝脏均可见门静脉分支和门脉纤维化的程度不同的闭塞性改变。一些中大型门静脉的纤维性内膜增厚伴管腔狭窄,呈随机分布,但这种病变具有特征性,很可能代表已机化的壁内血栓。在部分病例中可见紧密排列的结节状增生性实质区,其间被受压的肝细胞、巨大窦和铁质沉着所分隔。

结论

非肝硬化性门静脉纤维化是该疾病的合理命名,它可以进展为终末期肝病。它代表了一种单一实体,由于其异质性形态表现的主导因素,被认为是不同的疾病,并给予了不同的名称。

相似文献

1
Non-cirrhotic portal fibrosis: one disease with many names? An analysis from morphological study of native explant livers with end stage chronic liver disease.非肝硬化性门静脉纤维化:一种疾病,多种命名?一项对终末期慢性肝病原位肝移植标本进行形态学研究的分析。
J Clin Pathol. 2011 Jul;64(7):592-8. doi: 10.1136/jcp.2010.087395.
2
Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.肝硬化前期胆道疾病中的肝移植:门静脉高压常与结节性再生性增生和闭塞性门静脉病相关。
Am J Surg Pathol. 2006 Nov;30(11):1454-61. doi: 10.1097/01.pas.0000213286.65907.ea.
3
End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program.终末期非酒精性脂肪性肝病:肝移植供体肝活检测定中对隐匿性肝硬化与非酒精性脂肪性肝病肝组织形态学特征及其关系的评价
Hum Pathol. 2010 Mar;41(3):425-30. doi: 10.1016/j.humpath.2009.06.021. Epub 2009 Dec 1.
4
Slow cirrhosis--or no cirrhosis? a lesion causing benign intrahepatic portal hypertension.缓慢进展性肝硬化——还是无肝硬化?一种引起良性肝内门静脉高压的病变。
J Pathol. 1982 Jul;137(3):253-72. doi: 10.1002/path.1711370309.
5
Liver transplantation for severe intrahepatic noncirrhotic portal hypertension.肝移植治疗重度肝内非肝硬化门静脉高压症
Liver Transpl. 2005 Jun;11(6):627-34; discussion 610-1. doi: 10.1002/lt.20431.
6
Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension.肝硬化中的肝静脉和门静脉血栓形成:在实质细胞消亡和门静脉高压发展中的可能作用。
Hepatology. 1995 May;21(5):1238-47.
7
Clinicopathological features of nine cases of non-cirrhotic portal hypertension: current definitions and criteria are inadequate.9例非肝硬化性门静脉高压症的临床病理特征:现行定义和标准并不充分。
Histopathology. 2003 Mar;42(3):251-64. doi: 10.1046/j.1365-2559.2003.01586.x.
8
[Liver pathology in idiopathic portal hypertension].[特发性门静脉高压症的肝脏病理学]
Zhonghua Gan Zang Bing Za Zhi. 2007 May;15(5):374-7.
9
The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis.肉芽肿性静脉炎和血栓形成在结节病肝硬化和门静脉高压发病机制中的作用。
Hepatology. 1997 Sep;26(3):554-60. doi: 10.1002/hep.510260304.
10
Histological features in western patients with idiopathic non-cirrhotic portal hypertension.特发性非肝硬化性门静脉高压症西方患者的组织学特征。
Histopathology. 2013 Jun;62(7):1083-91. doi: 10.1111/his.12114. Epub 2013 Apr 18.

引用本文的文献

1
Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management.非肝硬化性门脉纤维化/特发性门脉高压:亚太肝脏研究学会诊断与管理推荐意见
Hepatol Int. 2024 Dec;18(6):1684-1711. doi: 10.1007/s12072-024-10739-6. Epub 2024 Nov 15.
2
Histopathological features of idiopathic portal hypertension: A systematic review and meta-analysis.特发性门静脉高压症的组织病理学特征:系统评价和荟萃分析。
Sci Prog. 2024 Jul-Sep;107(3):368504241264996. doi: 10.1177/00368504241264996.
3
Spectrum of histopathological changes in patients with non-cirrhotic portal fibrosis.
非肝硬化性门静脉纤维化患者的组织病理学变化谱。
Hepatol Int. 2018 Mar;12(2):158-166. doi: 10.1007/s12072-018-9857-y. Epub 2018 Apr 12.
4
Pathology of idiopathic non-cirrhotic portal hypertension.特发性非肝硬化性门静脉高压症的病理学。
Virchows Arch. 2018 Jul;473(1):23-31. doi: 10.1007/s00428-018-2355-8. Epub 2018 Apr 12.
5
Pathology of idiopathic non-cirrhotic portal hypertension.特发性非肝硬化性门静脉高压症的病理学
Hepatol Int. 2017 Sep;11(5):409-411. doi: 10.1007/s12072-017-9823-0. Epub 2017 Sep 13.
6
Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options.特发性非肝硬化性肝内门静脉高压症(NCIPH)——发病机制的新见解及新出现的治疗选择
J Clin Exp Hepatol. 2014 Sep;4(3):247-56. doi: 10.1016/j.jceh.2014.07.005. Epub 2014 Jul 28.
7
Noncirrhotic intrahepatic portal hypertension: towards a unifying definition and etiology.非肝硬化性肝内门静脉高压症:迈向统一的定义与病因学
Indian J Gastroenterol. 2014 Jul;33(4):308-9. doi: 10.1007/s12664-014-0482-y. Epub 2014 May 31.
8
Analysis of inconsistencies in terminology of spinal and bulbar muscular atrophy and its effect on retrieval of research.脊髓延髓肌萎缩症术语不一致性分析及其对研究检索的影响
J Med Libr Assoc. 2013 Apr;101(2):147-50. doi: 10.3163/1536-5050.101.2.010.